What's new

Traditional Chinese Medicine (TCM) news, info

Human Pulse Diagnosis for Medical Assessments Using a Wearable Piezoelectret Sensing System [Video]
ASN_Square_blue-1-80x80.jpg

By Advanced Science News Video
Posted on October 4, 2018


The pulse of our heart reflects our health and emotions, making monitoring it a long-used, powerful diagnostic tool. Current wearables for pulse sensing use optical sensors, which lack sensitivity and stability.

In their paper in Advanced Functional Materials, Dr. Junwen Zhong from the University of California Berkeley, Prof. Ying Dong from Tsinghua University, Prof. Liwei Lin from Tsinghua University and the University of California Berkeley, and their co-workers report a wearable piezoelectret sensor for pressure-based human pulse measurement.

Prof. Liwei Lin: “The goal for this work is actually trying to emulate the traditional Chinese medicine. It has been thousands of years that doctors could just use three fingers to measure the pulse and then tell many different health conditions of human beings.

Yao Chu: “In this work we have developed an active sensing system using a flexible piezoelectric film that has high sensitivity and excellent stability for human pulse acquisition.

A wrist-based sensor precisely detects pulse-related pressure changes. Pulse intervals are narrowly distributed for healthy individuals, but widely spread for diagnosed arrhythmia patients.

Combining the sensor with a pressure cuff directly yields the mean arterial pressure and allows calculation of the diastolic pressure and the systolic pressure.

A three-channel sensor was designed to imitate traditional Chinese medicine. The signal decrease over the three measuring points–Cun, Guan, and Chi–and a weaker pulse for female over male subjects could be detected.

Prof. Liwei Lin: “And the goal for this project actually is to use the device we have and gather the data and send it to the cloud, and doing this big-data-type analysis, and to tell people their health condition.


Human Pulse Diagnosis for Medical Assessments Using a Wearable Piezoelectret Sensing System [Video] - Advanced Science News
 
Popularizing TCM worldwide
By Zheng Yiran in Beijing and Ma Jingna in Lanzhou | China Daily | Updated: 2019-02-18 07:58
f_art.gif
w_art.gif
in_art.gif
more_art.gif


5c69f514a3106c65fffa4966.jpeg
An official (second from left) from the drug regulatory authority of Australia inspects the production line of Lanzhou Foci Pharmaceutical Co Ltd in Lanzhou, Gansu province. [Photo provided to China Daily]

Lanzhou Foci Pharma's smart plants make its concentrated pills potent planet-wide

Gansu province-based Lanzhou Foci Pharmaceutical Co Ltd is becoming well known the world over for its concentrated pills, a unique type of traditional Chinese medicine or TCM for a range of diseases or conditions like asthma, diabetes, tuberculosis, cataract, hypertension and hepatitis.

These pills have been exported to 28 countries and regions already, including the United States, Canada, Australia, Japan, Brazil and Singapore, suggesting they are gaining traction in the global drug market for their efficacy.

The pills contain Chinese herbal extracts in concentrated form, so a very small amount is potent and can prove effective. The pill is much smaller and lighter than conventional medicines. Patients only need to take two such pills to achieve the same efficacy as five normal pills. Therefore, the concentrated pills are popular among foreign patients because they would like to take as few pills as possible.

Foci Pharma's concentrated pills are easy to swallow and absorb. They also have a relatively longer shelf life, company executives said.

"Overseas patients trust our products, because we use authentic ingredients, superb craftsmanship, to produce medicine that is effective and easy to take," said Sun Yu, general manager of Foci Pharma.

The brand was founded by Yu Huiguan in 1929. He invented the concentrated pill, and used then cutting-edge technology to improve TCM.

Two years later, Foci Pharma began to export its concentrated pills to Japan and Southeast Asian countries.

Historical records show that the concentrated pill proved popular soon after it was introduced in markets abroad-patients spoke highly of it, and demand outstripped supply.

Zhang Bihua, associate chief pharmacist of the department of pharmacy at Beijing Hospital, said: "Concentrated pills are small in size, so patients find them easy to take. The medicine is efficacious. In addition, concentrated pills are mold-proof."

The company now owns 25 production lines, which are all approved by drug regulators in countries like Australia, Japan and Ukraine.

5c69f514a3106c65fffa496c.jpeg
A lab technician at work at the production line of Foci Pharmaceutical Co Ltd in Lanzhou. [Photo/Xinhua]

Last year, the company moved its headquarters to an industrial park in Lanzhou New Area, where it has set up an intelligent or smart manufacturing plant and a digital workshop.

The company strives to improve production efficiency, lower production cost, enhance manufacturing environment, as well as increase the competitiveness and added value of TCM, company executives said.

It has also built a medical industrial park in Weiyuan, Gansu province, and took part in the nation's TCM standardization project, in an effort to build an enterprise with an industry-wide chain, to guarantee top quality of its medicines.

"As an international traditional Chinese medicine company, ever since our establishment, the company has been exporting traditional Chinese medicine to the outside world. During the export process, quality is always our priority. It's high quality that helps the company's brand to make an impact on the international market," Sun said.

For many years, the company has been focusing on research in TCM to make them conform to international standards. This effort has paid off: when the company entered the Brazilian market in 2017, it needed just two months to go through the registration of over 50 of its products.

To train local doctors, it established the TCM Development Center in Brazil. With the help of the China Chamber of Commerce for Import and Export of Medicines and Health Products, Foci Pharma connected with Brazil's health department, to help promote TCM in Brazil.

"We actively explore new modes of trade in TCM services, and make efforts in disseminating TCM culture, establishing national standards for TCM, promoting TCM to enter other countries' public healthcare systems, establishing overseas TCM centers, training local TCM professionals, as well as establishing a commercial presence overseas.

"We aim at accelerating the process of TCM internalization and standardization, to make sure it develops in a healthy and sustainable manner overseas," Sun said.

In 2017, the company's sales revenue was 501.14 million yuan ($74.23 million), up almost 38 percent year-on-year. More than 28 million yuan of its revenue, or 5.6 percent, came from overseas, up more than 14 percent year-on-year.

In the same year, Foci Pharma was among the top 10 TCM exporters awarded by the China Chamber of Commerce for Import and Export of Medicines and Health Products.
 
World's first TCM evidence-based medical center established
Source: Xinhua| 2019-03-13 01:15:10|Editor: yan

BEIJING, March 12 (Xinhua) -- The Chinese traditional medicine (TCM) evidence-based medical center, the world's first organization of such kind, was officially established Tuesday in the China Academy of Chinese Medical Sciences (CACMS).

The center will pool together efforts of CACMS and other organizations like Beijing University of Chinese Medicine for TCM evidence-based research.

Evidence-based medicine is a widely-used approach in medical practice that is intended to optimize decision-making in treating individual patients by emphasizing the use of evidence from well-designed and well conducted research.

Under this approach, clinical evidence serves as the main basis for evaluating effectiveness and safety of treatment. Though increasingly recognized around the world, TCM still lacks evidence justifying its clinical effectiveness and safety, which according to experts hinders it from "going global."

"Evidence-based medical studies evaluate the clinical verifiability and effectiveness of a medical theory with scientific examination and analysis," said Huang Luqi, academician with the Chinese Academy of Engineering and head of CACMS, at a Tuesday event marking the center's establishment.

Combining evidence-based medical studies and TCM's features will help enhance clinical effectiveness of TCM, as well as provide opportunities for TCM to prove its medical values to the world, Huang said.

Former Director-General of World Health Organization Margaret Chan said TCM had served the health needs of people in China and beyond for several thousand years and its safety and effectiveness deserved to be recognized.

There should not be barriers between TCM and western medicine, which both should join forces to serve people's health needs, she said.
 
NEWS RELEASE 18-APR-2019
Ginkgo seed extracts show antibacterial activity on skin pathogens
Experiments were guided by a prescription in a 16th-century text

EMORY HEALTH SCIENCES
The fan-shaped leaves of a ginkgo tree on the Emory University campus. CREDIT: Emory University

Extracts from the seeds of the Ginkgo biloba tree show antibacterial activity on pathogens that can cause skin infections such as acne, psoriasis, dermatitis and eczema, a study at Emory University finds. Frontiers in Microbiology is publishing the results of laboratory experiments showing that the extracts inhibit the growth of Cutibacterium acnes, Staphylococcus aureus and Streptococcus pyogenes.

A nearly 200-year-old copy of a 16th-century text on traditional Chinese medicine, the Ben Cao Gang Mu, guided the researchers in their experiments. "It was like blowing the dust off knowledge from the past and rediscovering something that had been there all along," says Xinyi (Xena) Huang, co-first author of the paper.

Huang, a native of China, began the project for her senior thesis as a biology major at Emory. She has since graduated from Emory and is now a student at the University of Maryland School of Pharmacy.

"To the best of our knowledge, this is the first study to demonstrate the antibacterial activity of ginkgo seeds on skin pathogens," says Cassandra Quave, senior author of the paper and assistant professor at Emory's Center for the Study of Human Health and the School of Medicine's Department of Dermatology. "This paper is just one more example of how much we still have to learn about the pharmacological potential of the complex chemistry of plants."

Quave is an ethnobotanist, studying how indigenous people use plants in their healing practices, to uncover promising candidates for new drugs.

"Our results give validity to the use of ginkgo seeds as a topical antimicrobial as prescribed in this 16th-century text," says Francois Chassagne, co-first author of the paper and a pharmacist in the Quave lab.

Many hurdles remain, he adds, before ginkgo seed extracts could be considered for use in a modern-day medical context. In its concentrated form, the main compound that a statistical analysis identified as likely responsible for the antibacterial activity, ginkgolic acid C15:1, has been demonstrated to have skin toxicity.

"One possible strategy in the search for new antibiotics would be to investigate ways to modify the structure of the particular ginkgolic acid tied to the antibacterial activity, to try to improve its efficacy and also to reduce its toxicity to human skin cells," Chassagne says.

James Lyles, a chemist in the Quave lab, is an additional co-author of the study.

The ginkgo tree, a native of China, is one of the oldest tree species, going back at least 270 million years. The tree is known for its distinctive fan-shaped leaves and its long history in traditional Chinese medicine. Modern-day researchers have studied ginkgo extensively in search of medical benefits for everything from memory enhancement to macular degeneration, but there is still "no conclusive evidence that ginkgo is helpful for any health condition," according to the web page of the National Institutes of Health's National Center for Complementary and Integrative Health.

Most previous studies have focused on the ginkgo leaves.

When walking across campus, pondering what to focus on for her senior thesis, a ginkgo tree caught Huang's eye. She knew that the tree was used in traditional Chinese medicine, although she did not know any details, so she decided to research it.

Huang's interest grew when she learned that Emory has an 1826 version of the Ben Cao Gang Mu, or Compendium of Materia Medica. Considered the most comprehensive book on traditional Chinese medicine, it was compiled and written in the 16th century by Li Shi-zhen during the heyday of the Ming Dynasty. The original compendium is vast, encompassing dozens of volumes, but Huang had only seen greatly condensed versions that are sold in Chinese bookstores.

Emory's copy resides in the Candler School of Theology's Pitts Theology Library. The 1826 version passed at one stage through a London book dealer. The unnumbered pages are block-printed in Chinese characters, but at some point were rebound into 10 volumes with covers labeled in English.

Huang never imagined she would be touching such an old copy of the Ben Cao Gang Mu. "You can feel the history in it," she says. "The paper is so yellow, thin and fragile that I was afraid I would break the pages as I was turning them."

A volume labeled "Grains, Vegetables, Fruits" described 17 traditional uses for the ginkgo seed, including eight for skin disorders such as chapped hands and feet, rosacea, crab louse-induced itchiness, dog-bite wound abscesses and pustules. Li Shi-Zhen recommended preparing a paste of ground up seeds mixed with rice wine or other alcohol, or by immersing the crushed seeds in rape seed oil. The paste could then be applied to the affected area.

A previous study found that ginkgo seed coats demonstrated antibacterial activity against some intestinal bacterial pathogens. And ginkgo leaves have shown antibacterial activity on both some intestinal bacteria and on the skin pathogen S. aureus.

Huang, however, wanted to test the information she had gleaned from the ancient text for the use of ginkgo seeds as a topical treatment for skin disorders. Skin pathogens are of particular interest to the Quave lab, which focuses on finding new approaches to treat antibiotic-resistant bacteria.

Huang gathered ginkgo samples for testing. Extractions from the seeds were processed as closely as possible to the recommendations of the Ben Cao Gang Mu, using either water, ethanol or rape seed oil. Huang and Chassagne conducted microbial experiments -- including the evaluation of ginkgo extracts from the seed nut, immature seeds and the seed coat -- on 12 different bacterial strains.

The results showed that the ginkgo seed coats and the immature seeds exhibited antibacterial activity on three of the strains tested: C. acnes, S. aureus and S. pyogenes. Statistical analysis also found a positive correlation between the antimicrobial activity of the ginkgo samples and the concentration of ginkgolic acid C15:1, suggesting it was involved in the activity.

"Our finding is still in a basic, benchtop phase -- these extracts have not yet been tested in animal or human studies -- but it is still a thrill for me to learn that this ancient story in the Ben Cao Gang Mu appears to be real," Huang says. "As a student pharmacist, this gives me more appreciation for the value of using ancient plant remedies to guide modern-day research."



Ginkgo seed extracts show antibacterial activity on skin pathogens | EurekAlert! Science News
 
NEWS RELEASE 23-APR-2019
Acupuncture equals disease prevention say new studies
MARY ANN LIEBERT, INC./GENETIC ENGINEERING NEWS

Medical Acupuncture, the Official Journal of the American Academy of Medical Acupuncture, presents evidence-based clinical articles, case reports, and research findings that integrate concepts from traditional and modern forms of acupuncture with allopathic medicine. CREDIT:
Mary Ann Liebert, Inc., publishers

New Rochelle, NY, April 23, 2019--Well-recognized for its therapeutic effects, acupuncture is increasingly being appreciated for its ability to promote wellness and contribute to the prevention of a broad range of conditions. A new study, which demonstrates the promise of acupuncture as a complementary approach in improving psychological and pain symptoms associated with post-traumatic stress disorder (PTSD) following a natural disaster, is published as part of a Special Issue on Acupuncture to Foster Health Promotion and Disease Prevention in Medical Acupuncture, a peer-reviewed journal from by Mary Ann Liebert, Inc., publishers. Click here to read the full-text article free on the Medical Acupuncture website through May 23, 2019.

The article entitled "An Observational Study on Acupuncture for Earthquake-Related Post-Traumatic Stress Disorder: The Experience of the Lombard Association of Medical Acupuncturists/Acupuncture in the World, in Amatrice, Central Italy" was coauthored by Carlo Moiraghi, MD and Paola Poli, MD, Medical Association of Lombard Acupuncture (Milan, Italy), and Antonio Piscitelli, MD, School of Acupuncture and Traditional Chinese Medicine (Milan, Italy).

The researchers studied the effects of acupuncture on the victims of a 6.0 earthquake that caused nearly 300 deaths and left 30,000 people homeless in Amatrice, Central Italy. The acupuncture effort was led by two medical associations: Lombard Association of Medical Acupuncturists (ALMA) and Acupuncture in the World (AGOM).

Treatments were performed by medical doctors who had at least 3 years of clinical experience with acupuncture. Each subject received four 20-minute acupuncture treatments over consecutive days. Before the acupuncture treatment, more than 68% of the study participants reported having both pain and psychological symptoms that could be associated with PTSD. After the third treatment, both the pain and psychological symptom scores had significantly improved, with no serious adverse effects attributed to the treatment.

Co-Guest Editor Songxuan Zhou Niemtzow, MD (China), a Traditional Chinese Medicine physician in Alexandria, VA, states, "If acupuncture had an alternative name, it could be called 'prevention,'" in her editorial entitled "Acupuncture: Prevention Workarounds."

In the editorial "Prevention at the Core of Acupuncture," Co-Guest Editor Nadia Volf, MD, PhD, Paris XI University (Paris, France) writes "although acupuncture can be a wonderful tool for treating a number of diseases, this therapy can be an even more wonderful tool for preventing them."



Acupuncture equals disease prevention say new studies | EurekAlert! Science News
 
NEWS RELEASE 18-APR-2019
Ginkgo seed extracts show antibacterial activity on skin pathogens
Experiments were guided by a prescription in a 16th-century text

EMORY HEALTH SCIENCES
The fan-shaped leaves of a ginkgo tree on the Emory University campus. CREDIT: Emory University

Extracts from the seeds of the Ginkgo biloba tree show antibacterial activity on pathogens that can cause skin infections such as acne, psoriasis, dermatitis and eczema, a study at Emory University finds. Frontiers in Microbiology is publishing the results of laboratory experiments showing that the extracts inhibit the growth of Cutibacterium acnes, Staphylococcus aureus and Streptococcus pyogenes.

A nearly 200-year-old copy of a 16th-century text on traditional Chinese medicine, the Ben Cao Gang Mu, guided the researchers in their experiments. "It was like blowing the dust off knowledge from the past and rediscovering something that had been there all along," says Xinyi (Xena) Huang, co-first author of the paper.

Huang, a native of China, began the project for her senior thesis as a biology major at Emory. She has since graduated from Emory and is now a student at the University of Maryland School of Pharmacy.

"To the best of our knowledge, this is the first study to demonstrate the antibacterial activity of ginkgo seeds on skin pathogens," says Cassandra Quave, senior author of the paper and assistant professor at Emory's Center for the Study of Human Health and the School of Medicine's Department of Dermatology. "This paper is just one more example of how much we still have to learn about the pharmacological potential of the complex chemistry of plants."

Quave is an ethnobotanist, studying how indigenous people use plants in their healing practices, to uncover promising candidates for new drugs.

"Our results give validity to the use of ginkgo seeds as a topical antimicrobial as prescribed in this 16th-century text," says Francois Chassagne, co-first author of the paper and a pharmacist in the Quave lab.

Many hurdles remain, he adds, before ginkgo seed extracts could be considered for use in a modern-day medical context. In its concentrated form, the main compound that a statistical analysis identified as likely responsible for the antibacterial activity, ginkgolic acid C15:1, has been demonstrated to have skin toxicity.

"One possible strategy in the search for new antibiotics would be to investigate ways to modify the structure of the particular ginkgolic acid tied to the antibacterial activity, to try to improve its efficacy and also to reduce its toxicity to human skin cells," Chassagne says.

James Lyles, a chemist in the Quave lab, is an additional co-author of the study.

The ginkgo tree, a native of China, is one of the oldest tree species, going back at least 270 million years. The tree is known for its distinctive fan-shaped leaves and its long history in traditional Chinese medicine. Modern-day researchers have studied ginkgo extensively in search of medical benefits for everything from memory enhancement to macular degeneration, but there is still "no conclusive evidence that ginkgo is helpful for any health condition," according to the web page of the National Institutes of Health's National Center for Complementary and Integrative Health.

Most previous studies have focused on the ginkgo leaves.

When walking across campus, pondering what to focus on for her senior thesis, a ginkgo tree caught Huang's eye. She knew that the tree was used in traditional Chinese medicine, although she did not know any details, so she decided to research it.

Huang's interest grew when she learned that Emory has an 1826 version of the Ben Cao Gang Mu, or Compendium of Materia Medica. Considered the most comprehensive book on traditional Chinese medicine, it was compiled and written in the 16th century by Li Shi-zhen during the heyday of the Ming Dynasty. The original compendium is vast, encompassing dozens of volumes, but Huang had only seen greatly condensed versions that are sold in Chinese bookstores.

Emory's copy resides in the Candler School of Theology's Pitts Theology Library. The 1826 version passed at one stage through a London book dealer. The unnumbered pages are block-printed in Chinese characters, but at some point were rebound into 10 volumes with covers labeled in English.

Huang never imagined she would be touching such an old copy of the Ben Cao Gang Mu. "You can feel the history in it," she says. "The paper is so yellow, thin and fragile that I was afraid I would break the pages as I was turning them."

A volume labeled "Grains, Vegetables, Fruits" described 17 traditional uses for the ginkgo seed, including eight for skin disorders such as chapped hands and feet, rosacea, crab louse-induced itchiness, dog-bite wound abscesses and pustules. Li Shi-Zhen recommended preparing a paste of ground up seeds mixed with rice wine or other alcohol, or by immersing the crushed seeds in rape seed oil. The paste could then be applied to the affected area.

A previous study found that ginkgo seed coats demonstrated antibacterial activity against some intestinal bacterial pathogens. And ginkgo leaves have shown antibacterial activity on both some intestinal bacteria and on the skin pathogen S. aureus.

Huang, however, wanted to test the information she had gleaned from the ancient text for the use of ginkgo seeds as a topical treatment for skin disorders. Skin pathogens are of particular interest to the Quave lab, which focuses on finding new approaches to treat antibiotic-resistant bacteria.

Huang gathered ginkgo samples for testing. Extractions from the seeds were processed as closely as possible to the recommendations of the Ben Cao Gang Mu, using either water, ethanol or rape seed oil. Huang and Chassagne conducted microbial experiments -- including the evaluation of ginkgo extracts from the seed nut, immature seeds and the seed coat -- on 12 different bacterial strains.

The results showed that the ginkgo seed coats and the immature seeds exhibited antibacterial activity on three of the strains tested: C. acnes, S. aureus and S. pyogenes. Statistical analysis also found a positive correlation between the antimicrobial activity of the ginkgo samples and the concentration of ginkgolic acid C15:1, suggesting it was involved in the activity.

"Our finding is still in a basic, benchtop phase -- these extracts have not yet been tested in animal or human studies -- but it is still a thrill for me to learn that this ancient story in the Ben Cao Gang Mu appears to be real," Huang says. "As a student pharmacist, this gives me more appreciation for the value of using ancient plant remedies to guide modern-day research."



Ginkgo seed extracts show antibacterial activity on skin pathogens | EurekAlert! Science News
Thank you America for the study. Chinese cannot do this type of research if they had not gone to a US school to get education
 
Chinese-UK project reveals ancient secrets of medicinal mint
24th April 2019

Scutellaria-baicalensis-2-Credit-Botanikfoto-615x340.jpg

The precious chemistry of a plant used for 2,000 years in traditional Chinese medicine has been unlocked in a project that raises the prospect of rapid access to a wide array of therapeutic drugs.

Carried out by CEPAMS – a partnership between the Chinese Academy of Sciences and the John Innes Centre – the project has successfully delivered a high-quality reference genome of the mint-family member Scutellaria baicalensis Georgi.

The plant, commonly known as Chinese Skullcap, is well-known in Traditional Chinese Medicine (TCM) and is cultivated worldwide for its therapeutic properties.

Preparations of its dried roots, ‘Huang Qin’, show pharmacological activities conferred by novel compounds called flavonoids, including antibacterial, antiviral, antioxidant, anti-cancer, liver-protective and neuroprotective properties.

Despite the commercial interest and increasing demand for Scutellaria, improvements through breeding have been limited by a lack of genome information.

The team took DNA from a single plant at the Shanghai Chenshan Botanical Garden and used a combination of sequencing strategies to assemble 93% of the genome organised into 9 subsets of information or “pseudo chromosomes.”

The development means that researchers are now able to identify the genes that produce a wealth of valuable compounds, and then turn them into drug candidates using metabolic engineering techniques in the lab.

The sequencing project outlined in the journal Molecular Plant, also provides a reference gateway for genetic exploration of other valuable members of the Lamiaceae or mint family.

“When I started getting the analysis back on the genome sequence it was like a revelation: it showed at a fundamental level how the pathway to valuable compounds evolved.” says Professor Cathie Martin of the John Innes Centre and one of the authors of the study.

“The sequence is so good that it can improve the understanding of all the other genome sequences in the mint family. This is a large family of plants that is hugely important in Traditional Chinese Medicine and flavourings.”

This study highlights the current revival in Traditional Chinese Medicine following the award of the Nobel Prize for Physiology and Medicine in 2015 to Professor You-you Tu for her discovery of artemisinin as a broad spectrum anti-malarial from Artemesia annua (wormwood).

Since then, pharmacology has started examining the healing properties of preparations from plants listed in the traditional texts, such as Shennong Bencaojing (The Divine Farmer’s Materia Medica) written between 200 and 250 AD. Such preparations have recently been reported as effective against a variety of complaints including as complementary cancer treatments.

Work on the reference genome and sequences from members of the same family has already started to deliver valuable information that could be applied to development of a wider range of remedies.

“This particular plant makes the bioactive compounds in the root, which means you have to wait three years for the plant to get big enough and of course in taking the root you destroy the plant,” said Professor Martin.

“We’ve screened some members of the same family that make similar compounds in the leaves which means you could get more sustainable therapeutics taken in a different way,” she added.

The full study: ‘The Reference Genome Sequence of Scutellaria baicalensis Provides Insights into the Evolution of Wogonin Biosynthesis’ is published in Molecular Plant journal.



Chinese-UK project reveals ancient secrets of medicinal mint | John Innes Centre
 
Traditional Chinese medicine ready for expanding international market
By Sun Haoran Source:Global Times Published: 2019/5/26 19:58:40

3aa2675f-152c-4b99-9845-4b0459cfc500.jpeg
Traders bargain inside the traditional Chinese medicine (TCM) market in Bozhou, East China's Anhui Province on Monday. The market reopened on Monday after the weeks-long Chinese Spring Festival holidays. The TCM market in Bozhou is said to be one of the most wide-ranging and active specialized markets for Chinese medicinal materials, with the market's annual sales standing at 30 billion yuan ($4.73 billion) in 2017. Photo: VCG

Chinese experts on Sunday hailed the World Health Organization's (WHO) formal approval of the inclusion of a chapter on traditional Chinese medicine (TCM) in the latest version of its influential global compendium.

"This is significant for the internationalization of TCM industry as it will help China establish a TCM disease statistics network linked to international standards," Liu Baoyan, president of the China Association of Acupuncture-Moxibustion, told the Global Times.

It would also promote the integration of TCM with the medical and health systems of countries around the world, Liu noted.

TCM is used in 183 countries and regions, the Xinhua News Agency reported.

Beijing has signed TCM cooperation agreements with more than 40 foreign governments, regions and organizations including the US, Russia, the UK, Germany, France, Canada and Italy.

Besides, a number of TCM centers have been established in countries and regions along the routes of China-proposed Belt and Road Initiative.

Countries such as Singapore and Thailand have partly or wholly legalized some TCM practices, Chinese media reports noted.

Students from India are the largest group studying at China Medical University, Diao Yefang, head of the teaching affairs office at the university's international education school, previously told the Global Times.

China has established intergovernmental mechanisms with South Korea, Singapore, and Malaysia.

The industry reaped more than 860 billion yuan ($130 billion) in 2016, and was growing at 20 percent annually, Xinhua reported, citing the State Administration of Traditional Chinese Medicine of China.

Meanwhile, the WHO's decision was not universally welcomed. Some foreign scientists questioned the safety of Chinese herbal medicines and the absence of double-blind evidence-based reports on its efficacy.

Animal rights advocates also warned that the decision would endanger animals such as tiger, pangolin, bear and rhino, whose organs were used in some TCM cures.

Even within China, critics worry that TCM can cause adverse drug reactions, of which the best-known issue was Houttuynia injections that killed at least 44 people. On June 1, 2006, China's State Food and Drug Administration temporarily suspended the use and approval of seven TCM injections including Houttuynia injections.

"Problems do exist in development of the TCM industry," Zhou Lihua, an expert with the AIDS research center at the Henan University of Traditional Chinese Medicine, told the Global Times on Sunday.

"However, TCM is based on more than 2,500 years of Chinese medical practice and has proven to be effective," Zhou said.
 
New Method Developed for Traditional Medicine Prescription Generation Based on Deep Learning Technology----Chinese Academy of Sciences
By LIU Jia | Dec 23, 2019

Chinese traditional herbal medicines have been widely recognized by more and more doctors, medical institutions and individuals in western countries. Especially in recent decades, various effective pure plant drugs extracted based on the experience of Chinese traditional herbal medicines consolidated their status in the medical field.

In medical application, the research on artificial intelligence methods based on deep learning have made breakthroughs. However, in traditional medicine, the diagnosis and treatment using intelligent traditional Chinese medicine (TCM) are still in its infancy.

In a recent study published in IEEE ACCESS, ZHENG Zeyu's team at Shenyang Institute of Automation of the Chinese Academy of Sciences have proposed an adaptive traditional Chinese medicine prescription generation model for intelligent TCM research. This method is based on the core idea of TCM diagnosis and treatment process - syndrome differentiation and treatment.

In the new model, the features of the patient’s symptom information are first extracted using deep recurrent neural network. Considering the severity of different symptoms of the patient, each herb in the prescription can then be dynamically generated according to the corresponding symptoms, realizing a process of intelligent automatic diagnosis and treatment of TCM.

Compared with previous study on intelligent TCM, this method is completely based on the learning method and does not need to manually design any rules in advance. Also, it shows good adaptability.

Apart from being an exploration in the research of intelligent traditional Chinese medicine, this method can inspire future study on applying artificial intelligence technology in outpatient diagnosis and treatment.

W020191223569942746579.png
The Traditional Chinese Medicine prescription generation model based on deep recurrent neural network (Image by LIU Zhi)
 
Traditional Chinese medicine applied in over half of confirmed patients in coronavirus-hit Hubei: official
Source: Xinhua| 2020-02-15 12:43:39|Editor: huaxia

WUHAN, Feb. 15 (Xinhua) -- Traditional Chinese medicine (TCM) has been applied in treating more than half of the confirmed patients of novel coronavirus (COVID-19) infection in China's Hubei Province, center of the epidemic, a senior official with the National Health Commission said Saturday.

"Since the beginning of the outbreak, the government has attached importance to both TCM and Western medicine by mobilizing the strongest scientific research and medical forces in both fields to treat the patients," said Wang Hesheng, deputy head of the commission, at a press conference, noting that the combination of TCM and Western medicine in treatment is an important feature of the fight against the epidemic.

TCM universities and hospitals across the country have sent 2,220 medical workers to Hubei to help combat the epidemic, according to Wang, also a member of the standing committee of the Hubei provincial Party committee.

TCM has also been used in the prevention and control of COVID-19 at the community level, he added.

"By coordinating the resources of traditional Chinese and Western medicine, we strive to improve the cure rate and reduce fatalities by the greatest possible amount to effectively safeguard the safety and health of the people," Wang noted.
 
Traditional Chinese medicine applied in over half of confirmed patients in coronavirus-hit Hubei: official
Source: Xinhua| 2020-02-15 12:43:39|Editor: huaxia

WUHAN, Feb. 15 (Xinhua) -- Traditional Chinese medicine (TCM) has been applied in treating more than half of the confirmed patients of novel coronavirus (COVID-19) infection in China's Hubei Province, center of the epidemic, a senior official with the National Health Commission said Saturday.

"Since the beginning of the outbreak, the government has attached importance to both TCM and Western medicine by mobilizing the strongest scientific research and medical forces in both fields to treat the patients," said Wang Hesheng, deputy head of the commission, at a press conference, noting that the combination of TCM and Western medicine in treatment is an important feature of the fight against the epidemic.

TCM universities and hospitals across the country have sent 2,220 medical workers to Hubei to help combat the epidemic, according to Wang, also a member of the standing committee of the Hubei provincial Party committee.

TCM has also been used in the prevention and control of COVID-19 at the community level, he added.

"By coordinating the resources of traditional Chinese and Western medicine, we strive to improve the cure rate and reduce fatalities by the greatest possible amount to effectively safeguard the safety and health of the people," Wang noted.

Traditional Western Medicine might work too:

Antibacterial, antifungal, and antiviral effects of three essential oil blends

3.3. Antiviral activity of AB1
Blend AB1 significantly reduced viral units for H1N1 and HSV1. For H1N1, a reduction greater than 99% (>2 log) was observed with 1% AB1 with a 60‐min contact time and a reduction greater than 99.99% (>4 log) with 80% and 40% AB1 after 60 min. For HSV1, a reduction greater than 99% was obtained with 1% and 40% AB1 after 60‐min contact time and a 99.99% reduction at 80% AB1 for 60 min. These results are consistent with previous work, which showed that E. globulus and C. zeylanicum EOs had antiviral activity on H1N1 and HSV1 (Astani et al., 2010; Vimalanathan & Hudson, 2014). For example, eucalyptus EO and its compounds 1,8 cineole and β‐caryophyllene exhibit an anti‐HSV1 activity by directly inactivating free‐virus particles and might interfere with virion envelope structures required for entry into host cells (Astani, Reichling, & Schnitzler, 2011; Astani et al., 2010). Commonly used antiviral medication (e.g., acyclovir and ganciclovir) inhibit DNA polymerases. Identifying substances with viral targets other than DNA polymerases are of particular interest to avoid resistance.

In a previous published study performed with a proprietary blend of rosemary, orange, clove, cinnamon, and eucalyptus EOs (On guard Wild™), efficacy was shown against H1N1, but was not tested against bacteria (Wu et al., 2010). In our study, AB1 was proven to be effective against both viruses and bacteria in particular, H1N1 virus, S. aureus and S. pneumoniae, two bacteria responsible for postinfluenza pneumonia (Chung & Huh, 2015). This dual activity could be of particular interest to treat influenza and also postinfluenza bacterial pneumonia infections, a leading cause of influenza‐associated death.

This in vitro study shows that blends AB1 and AB2 of C. zeylanicum, D. carota, E. globulus, and R. officinalis EOs possess a highly antimicrobial activity against Gram‐positive and Gram‐negative bacteria. Blend AB1 is also effective against viruses. Blend AF‐containing C. zeylanicum, D. carota, S. aromaticum, and O. vulgare EOs had a highly antifungal activity. This suggests that these blends could be effective to combat microorganisms involved in common, acute, and chronic human infections. Further exploration in clinical settings will be needed to confirm these in vitro results in terms of efficacy and also assess their safety.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552930/


Where do you think they get the ideas from?

Half of the top ten prescription drugs in the U.S. are of animal, plant, or microorganism origin. Our debt to the biosphere is even more dramatically revealed when we look at cancer medications: a remarkable three-quarters of anti-cancer drugs spring from the web of life.

https://www.rainforesttrust.org/owed-to-nature-medicines-from-tropical-forests/
 
上海市41例新型冠状病毒感染的肺炎患者同步应用中医药治疗
2020-01-31 10:45:54 来源: 新华网
新华社上海1月31日电(记者袁全、仇逸)上海市卫生健康委30日透露,截至1月29日,上海已对确诊的41例新型冠状病毒感染的肺炎患者同步应用中医药治疗,其中14人服用了中药饮片,27人服用中成药。

  目前,上海市级中医专家与市公共卫生临床中心中医科人员正密切观察病人用药后的临床症状,将根据治疗效果及时评估并完善诊疗方案。同时,按照国家和上海市统一部署和要求,上海市中医系统已有71名医护人员随上海医疗队支援武汉,另有4位中医专家已根据国家中医药管理局要求,做好前往武汉第一线支援的准备。

  据悉,《上海市新型冠状病毒感染的肺炎中医诊疗方案(试行)》已制定并印发。方案针对医学观察期、临床治疗期及恢复期,分时期和临床表现推荐用药及处方。例如,若市民发现自身存在一些乏力伴发热症状,在医学观察期内,可选择服用定量的金花清感颗粒、连花清瘟胶囊、疏风解毒胶囊或防风通圣丸。

  上海中医药大学附属曙光医院呼吸科主任张炜表示,方案中的推荐用药是针对有症状及在诊疗过程中的人群使用,不建议无相关病症人群服用。
Google translate:

Forty-one patients with pneumonia infected by NCP in Shanghai had simultaneous application of traditional Chinese medicine treatment
2020-01-31 10:45:54 Source: Xinhuanet

Xinhua News Agency, Shanghai, January 31st (Reporter Yuan Quan, Qiu Yi) Shanghai Municipal Health and Health Commission revealed on the 30th that as of January 29th, Shanghai has applied 41 Chinese patients with pneumonia infected with novel-type coronavirus to the simultaneous treatment of Chinese medicine. Of these, 14 took Chinese herbal medicine pieces, and 27 took Chinese patent medicine.

At present, Shanghai-level TCM experts and TCM staff of the Municipal Public Health Clinical Center are closely observing the clinical symptoms of patients after medication, and will promptly evaluate and improve the diagnosis and treatment plan according to the treatment effect. At the same time, in accordance with the unified deployment and requirements of the State and Shanghai, 71 medical staff in the Shanghai Traditional Chinese Medicine System have supported Wuhan with the Shanghai Medical Team, and another 4 TCM experts have completed the first trip to Wuhan as required by the State Administration of Traditional Chinese Medicine Preparation for line support.

It is reported that the "Traditional Chinese Medicine Diagnosis and Treatment Plan for Pneumonia Infected by New Coronavirus in Shanghai (Trial)" has been formulated and issued. The plan is aimed at medical observation period, clinical treatment period and recovery period, and recommends medications and prescriptions in different periods and clinical manifestations. For example, if citizens find that they have some symptoms of fatigue and fever, during the medical observation period, they can choose to take a certain amount of Jinhua Qinggan granules, Lianhua Qingwen capsules, Shufeng Jiedu capsules or Fangfeng Tongsheng pills.


Director of Respiratory Department, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine
Zhang Wei said, the recommended medication in the plan for people with symptoms and during the diagnosis and treatment, and it is not recommended for people without related symptoms.

上海有90%的确诊患者使用了中医治疗
2020-02-14 14:16 澎湃新闻

  2020年2月14日14:00,上海市新冠肺炎疫情防控系列新闻发布会,邀请市卫生健康委、市公安局、市民政局负责人出席并介绍情况。

  上海市卫生健康委新闻发言人郑锦介绍,医疗救治方面,上海进一步做好新冠肺炎确诊患者的医疗救治和急救转运,定点医院上海市公卫临床中心、复旦大学附属儿科医院全力以赴做好患者的医疗救治。

  进一步加强新冠肺炎疫情防控期间医疗安全管理,各级医疗机构完善医疗安全管理工作机制,同时加强患者安全管理和心理疏导,严格落实医疗安全事件报告制度。

  继续强化中西医协同,全力提升整体临床救治水平,定点医院收治的确诊患者中有90%的病例使用了中医治疗。

  继续做好关心支持上海支援武汉医疗队工作。
Google translate:

90% of confirmed patients in Shanghai used Chinese medicine
2020-02-14 14:16 thepaper.cn news

At 14:00 on February 14, 2020, Shanghai NCP Pneumonia Epidemic Prevention and Control Press Conference. Persons in charge of the Municipal Health and Health Committee, the Municipal Public Security Bureau, and the Civil Affairs Bureau were invited to attend and report the situation.

Zheng Jin, spokesman for the Shanghai Municipal Health Committee said, in terms of medical treatment,
Shanghai will further do a good job in medical treatment and emergency transfer of patients diagnosed with new coronary pneumonia. The designated hospital Shanghai Public Health Clinical Center and the pediatric hospital affiliated to Fudan University will go all out to do a good job in medical treatment.

The medical safety management during the NCP pneumonia epidemic prevention and control will be further strengthened. Medical institutions at all levels will improve the medical safety management working mechanism, strengthen the patient safety management and psychological counseling, and strictly implement the medical safety incident reporting system.

They will continue to strengthen collaboration between Chinese and Western medicine, efforts were made to improve the overall level of clinical treatment, and 90% of the confirmed patients admitted to designated hospitals were treated with Chinese medicine.

They will continue to do a good job in supporting and supporting the Shanghai Medical Team in Wuhan.

22岁新冠肺炎患者回忆在上海被治愈:服用氯化钾、中药等
澎湃新闻记者 马作宇 陈斯斯

2020-02-15 11:29 来源:澎湃新闻

2月15日上午,在上海市公共卫生临床中心, 32例新型冠状病毒感染的肺炎病例,经定点医疗机构医护人员精心诊治和护理,专家组评估,认为符合国家卫生健康委最新的新型冠状病毒感染的肺炎确诊病例解除隔离和出院标准,于当日出院。这是自上海出现新型冠状病毒肺炎疫情至今,病例出院人数最多的一天。

今年22岁的望女士也是2月15日出院的病人之一,回顾自己的治疗过程,她相信,积极的心态非常重要,“当前有那么多的医护人员奋斗在一线抗疫,每天治愈出院的人数大大高出死亡人数,一定要坚定信心,才能祛除病魔。”

望女士是武汉一家旅游公司的领队。1月21日她带领旅游团队从武汉到新加坡、印尼,1月23日得知武汉封城后,经公司决策商量,最终落地上海。

她表示,1月26日在上海机场落地时,当时有2位旅客回到了郑州,她被留在上海并去寻找酒店入住,“当时酒店方面告诉我,无法接待来自湖北的客人,政府给大家安排了统一住的地方,我就按照酒店给我的地址,来到了一家酒店。酒店里有医护人员、工作人员,他们给我们完成了消毒,还发放了酒精消毒片。随后我们办理入住,统一隔离14天,我有同事也一起被隔离,但他们都没有被确诊,目前已经回到了武汉。”

2月3日,在酒店隔离期的第9天,望女士发现自己有些头晕乏力、不舒服,但没有出现发烧、咳嗽的症状,她立刻把情况反馈给医护人员。在医护人员的建议下,她随即到医院进行检查,做了抽血以及肺部CT,“CT检查发现我肺部有炎症。”望女士说,因此她被列为疑似病例进行隔离留观。

2月4日上午,病毒核酸检测结果阳性,望女士被确诊给新冠肺炎,“当时我不害怕,因为我知道自己属于一名轻症患者,有工作人员马上将我转移到上海市公共卫生临床中心,这里有专家组和专业的医护人员家给我们治疗,我很放心。”

在隔离病房里,一日三餐都有医护人员给望女士送来饮用水、水果、餐点等,前五天治疗中,望女士服用的是一种抗艾滋病药物,5天后医生为她换药,“吃的是氯化钾,主要为了补充钾元素,另外还有一种是为了防止肝硬化的药物。”望女士介绍。

每隔2天,医护人员都会给望女士做一次肺部CT,一日三次的体温检测以及血压、心率测试,看病情是否好转,觉得自己病情好转之后,医生又帮她换了中药治疗,采取中西医结合治疗的方式。

“在整个治疗期间,我做了4次CT以及4次病毒核酸检测,最终符合出院标准。医生也提醒我说一周后需要来院在复查一次,也给我了一张血浆捐赠告知书。”望女士说,之所以自己能那么快康复,主要是因为这里的医护人员的努力,她很感谢政府,感谢国家,感谢所有在前线跟病毒战斗的医护人员,因此她决定捐赠出自己的血浆,帮助更多的人。

望女士表示,在治疗过程中,一定要保持积极的心态,要相信一定可以战胜病毒,“当前有那么多的医护人员奋斗在一线抗疫,每天治愈出院的人数大大高出死亡人数,一定要坚定信心,才能祛除病魔。”
Google translate:

22-year-old patient with new crown pneumonia recalls being cured in Shanghai: taking potassium chloride, Chinese medicine, etc.
thepaper.cn news reporter Ma Zuoyu Chen Sisi

2020-02-15 11:29 Source: thepaper.cn News

On the morning of February 15, at the Shanghai Public Health Clinical Center, 32 cases of NCP pneumonia patient, after careful diagnosis and treatment and care by medical staff at designated medical institutions, the expert group assessed that it was in line with the latest National Health Commission quarantine and discharge standards for confirmed cases of NCP pneumonia infection, and were released on the same day. This is the day that the largest number of patients have been discharged since the outbreak of new coronavirus pneumonia in Shanghai.

Ms. Wang, 22, is also one of the patients who was discharged on February 15th. Looking back on her treatment process, she believes that a positive attitude is very important. The number is much higher than the number of deaths, and we must strengthen our confidence to get rid of the disease. "

Ms. Wang is the leader of a travel company in Wuhan. On January 21st, she led the travel team from Wuhan to Singapore and Indonesia. After learning that Wuhan was closed on January 23rd, the company finally landed in Shanghai after making decisions and discussions with the company.

She stated that when landing at Shanghai Airport on January 26, two passengers returned to Zhengzhou at that time. She was left in Shanghai and went to find a hotel to check in. Arranged a place to stay, I came to a hotel according to the address given to me by the hotel. There were medical staff and staff in the hotel, they disinfected us and distributed alcohol disinfection tablets. Then we checked in and unified I have been quarantined for 14 days, but my colleagues have also been quarantined, but none of them have been diagnosed. They have now returned to Wuhan. "

On February 3, on the ninth day of the hotel's quarantine period, Ms. Wang found that she was dizzy, weak, and uncomfortable, but she did not have fever or cough. She immediately reported the situation to the medical staff. On the advice of the medical staff, she went to the hospital for an examination, took a blood draw and a CT of the lungs. "The CT examination found that my lungs were inflamed." Ms. Wang said that she was listed as a suspected case for isolation and observation.

On the morning of February 4, the viral nucleic acid test result was positive. Ms. Wang was diagnosed with new coronary pneumonia. "I was not afraid at that time because I knew that I belonged to a mild patient. Some staff immediately transferred me to the Shanghai Public Health Clinic. Center, there are expert groups and professional medical staff home to give us treatment, I am assured. "

In the isolation ward, medical staff brought drinking water, fruits, and meals to Ms. Wang during the three meals a day. During the first five days of treatment, Ms. Wang was taking an anti-AIDS drug, and the doctor changed her after 5 days. Medicine, "I eat potassium chloride, mainly to supplement potassium, and there is another medicine to prevent liver cirrhosis." Ms. Wang introduced.

Every 2 days, the medical staff will give Ms. Wang a lung CT, three times a day's temperature measurement and blood pressure, heart rate test to see if the condition is getting better. After feeling that her condition is getting better, the doctor will help her change the Chinese medicine treatment and take Traditional Chinese and western medicine treatment.

"During the entire treatment period, I performed 4 CTs and 4 viral nucleic acid tests, and finally met the discharge standards. The doctor also reminded me that I needed to come to the hospital one week later to review and gave me a notification of plasma donation." Wang The lady said that the reason why she can recover so quickly is mainly because of the hard work of the medical staff here. She is grateful to the government, the country, and all the medical staff fighting the virus on the front line, so she decided to donate her own plasma to help more people.

Ms. Wang said that during the treatment process, it is necessary to maintain a positive attitude and believe that the virus can be defeated. Only by strengthening confidence can we get rid of the disease. "

 
Last edited:
深圳新闻网
2月6日 15:01 来自 微博 weibo.com
【钟南山团队凉茶处方公开,两条药方不一样要看清!】
结合岭南气候、水土、饮食、人文等特点,并针对本次疫病资料,钟南山团队目前已拟定出新冠肺炎预防凉茶处方,定期为全院职工饮用,而此方也适用于居家隔离防疫的市民。

钟南山所在的广州医科大学附属第一医院是收治新冠肺炎患者、尤其是危重症患者的定点医院。医院组成了中医科新冠防治组,经讨论,并结合《广州医科大学新型冠状病毒感染的肺炎中医药诊疗方案》,拟定了预防新型冠状病毒肺炎凉茶处方,经医院相关部门的配合由食堂煎制,定期为全院职工饮用。

新型冠状病毒肺炎预防凉茶处方

柴胡10g 黄芪10g 薏米15g 苍术10g 麦冬15g 北沙参15g 生甘草10g 金银花15g 僵蚕10g 蝉衣5g 大黄5g 姜黄10g

以上药物10付,以水15L,煎取10L,每人每次饮200ml,每周2-3次。

如居家使用,以上药物1付,以水1.5L,煎取1L,3-4人分服,每周2-3次。

专家组认为,本次“疫病”有内外之因,外邪经皮毛或口鼻途径入侵人体,此为外因;人体正气相对不足难以抗邪,以致发病,此为内因。所谓“正气存内,邪不可干”。因此该防疫处方的主要目的在于“调理脾胃”与“祛邪辟秽”相结合,标本兼治。

在这个基础上,广医一院中医科新冠防治组总结往年治疗流感经验,结合岭南气候、水土、饮食、人文等特点,并针对本次疫病四诊资料,拟定出外感发热中药协定处方(注意此方适合外感发热人群,健康人群不建议),供广大市民参考使用。

防疫1号方

柴胡10g 黄芩10g 姜半夏10g

葛根20g 石菖蒲10g 路路通5g

石膏15g 大黄5g 党参10g

丹参15g 枳实10g 生甘草10g

以水1000ml, 煎取600ml, 分三次服用。可隔日一剂,或连服三天。
°钟南山团队凉茶处方公开,两条药方不一样要看...
Note:
For those that do not know who Zhong nanshan is, below is from Zhong Nanshan - Wikipedia

Zhong Nanshan (Chinese: 钟南山; pinyin: Zhōng Nánshān; born 20 October 1936)[1] is a Chinese epidemiologist and pulmonologist who discovered the SARS coronavirus in 2003.[2] He was president of the Chinese Medical Association from 2005 to 2009 and is currently the editor-in-chief of the Journal of Thoracic Disease.[2]

Zhong earned international fame for managing the SARS outbreak,[3] and was renowned for refuting the official line which downplayed the severity of the crisis.[4] He was voted one of China's top 10 scientists in 2010.[5] During the 2019–20 Wuhan coronavirus outbreak, he was again appointed a leading advisor in managing the crisis.[4]

Google translate:

Shenzhen News Network
February 6 15:01 from Weibo weibo.com
[Zhong Nanshan team's herbal tea prescription is open, the two prescriptions are different please pay attention! 】
Combining Lingnan's climate, soil and water, diet, humanities and other characteristics, and for this epidemic data, Zhong Nanshan's team has now formulated a prescription for new crown pneumonia prevention herbal tea, which is regularly consumed by the staff of the hospital, and this formula is also suitable for residents at home for isolation and epidemic prevention.

The First Affiliated Hospital of Guangzhou Medical University where Zhong Nanshan is located is the designated hospital for treating patients with new coronary pneumonia, especially critically ill patients. The hospital formed a new crown prevention and treatment group of Chinese medicine department. After discussion, and combined with "Guangzhou Medical University New Coronavirus Infected Pneumonia Diagnosis and Treatment Program", a prescription for herbal tea for prevention of new coronavirus pneumonia was prepared. , Regular drinking for the staff of the hospital.

Herbal tea prescription for new coronavirus pneumonia prevention

Bupleurum 10g, Astragalus 10g, Indica 15g, Atractylodes 10g, Ophiopogon 15 g

The above medicine is paid 10 times, 15L of water, 10L of decoction, each person drinks 200ml, 2-3 times a week.

If you use it at home, pay for the above medicine at a rate of 1.5L of water and 1L of decoction. 3-4 people will take it 2-3 times a week.

The expert group believes that this "epidemic" has internal and external causes. External evils invaded the human body through the fur or through the nose and nose. This is an external cause. The human body lacks the righteousness to fight against evil and causes disease. The so-called "righteousness is in the house, evil cannot be done." Therefore, the main purpose of this epidemic prevention prescription is to combine the "conditioning of the spleen and stomach" and "relieve the evil and remove the filth", and treat both the symptoms and the symptoms.

On this basis, the New Crown Control Group of the TCM Department of the First Hospital of Guangzhou Medical University summed up the experience of treating influenza in the past, combined with the characteristics of Lingnan's climate, soil and water, diet, and humanities, and based on the four diagnoses of the epidemic, formulated an exogenous fever Chinese medicine agreement prescription (note This side is suitable for people with exogenous fever, not recommended for healthy people), for reference by the general public.

Epidemic Prevention Party 1

Bupleurum 10g Scutellaria baicalensis 10g Ginger Pinellia 10g

Pueraria puerariae 20g, Stone calamus 10g, Lulutong 5g

Gypsum 15g Rhubarb 5g Codonopsis 10g

Salvia miltiorrhiza 15g

Take 1000ml of water and fry 600ml. Can be taken every other day or for three consecutive days.
° The prescription of herbal tea by Zhong Nanshan team is open. The two prescriptions are different depending on ...
 
Last edited:
News from 6 days ago, I highlighted the part that is relevant to this thread.

Guangdong going all-out on virus prevention as workers return
By ZHENG CAIXIONG in Guangzhou | chinadaily.com.cn | Updated: 2020-02-10 21:09

5e4155f3a31012820650f645.jpeg
Resident buildings and offices are seen in Shenzhen, South China's Guangdong province, Sept 6, 2019. [Photo/Agencies]

South China's Guangdong province is going all out for prevention and controlling the outbreak of the novel coronavirus pneumonia (NCP) in the country's most populous province.

With the return of a large number of migrant workers from around the country after the lunar new year holidays, the situation of preventing and controlling the novel coronavirus pneumonia is very severe in Guangdong, then relevant departments and organizations have to spare no efforts to prevent and fight against the epidemic, according to the provincial authorities on Monday.

Guangdong, one of the country's economic powerhouses, has a population of more than 110 million and the province also has the country's largest number of migrant workers, authorities said.

The province, window of China's reform and opening up, has more than 22 million migrant workers.

To help fight against the disease, Guangdong Provincial Medical Products Administration has approved a new medicine called Pneumonia No 1, a traditional Chinese medicine granule, to be first used in 30 designated hospitals to treat novel coronavirus pneumonia in the province from Saturday.

Tan Hanghua, a senior traditional Chinese medical doctor from Guangzhou No. 8 People's Hospital, said that Pneumonia No. 1 has been proven to be effective in curing light novel coronavirus pneumonia patients.

"And the traditional Chinese medicines would play an important role in fighting against the disease when they are widely used in clinic," said Tan who is one of major medical staff in developing Pneumonia No. 1.

Wei Mei, deputy general manager of Guangdong Yifang Pharmaceutical Co. Ltd, said the company has started production of Pneumonia No. 1 and the production cycle of the medicine, which consists of 16 traditional Chinese medicines, is about a week.

Starting Saturday, all patients treated at fever clinics in Guangdong have needed to receive nucleic acid testing of throat swab samples against the NCP.

The provincial authorities have ordered all the fever clinics in the province to strictly comply with all the current management standards.

"Those who have positive results of the nucleic acid testing will be immediately isolated for treatment," authorities said.

All the residents in the province have been required to register their identity cards and leave their addresses and contact phone numbers when they want to purchase medicines themselves to cure fever and cough from local pharmacies after a province-wide inspection campaign to seek the possible NCP patients and suspects starting the weekend.

Local neighborhood committees and property management companies also have been required to measure their body temperatures of all residents who want to enter into their housing estates and communities while residents are required to report their health conditions and relevant people they have contacted in recent weeks.

Meanwhile, the Guangdong Provincial Department of Transportation has now set up a total of 19 cross-province checkpoints in the province's expressway network to prevent imported NCP cases, while Guangzhou City Bureau of Transportation has required all the passengers to have their body temperature measured when they want to take the city's public transports, including buses, metro trains and ferries.

As the end of Sunday, Guangdong has reported a total of 1,151 confirmed NCP cases after 31 cases were reported on Sunday alone.

“肺炎1号方”获批用于广东30家定点救治医院
2020-02-09 07:21:51字号:A- A A+来源:南方日报
据南方日报2月8日报道,8日,广东省药品监督管理局官网发布最新消息,同意广州市第八人民医院申报的透解祛瘟颗粒(曾用名“肺炎1号方”)用于全省30家新型冠状病毒感染的肺炎定点救治医院临床使用。非定点医院申请调剂使用,将由省药监局予以优先审批。

20200209071149193.jpeg


省药监局、卫健委和中医药局联合发布的这份通知指出,疫情期间,允许广东省新型冠状病毒感染的肺炎定点救治医院,根据临床需要直接调剂使用透解祛瘟颗粒,无需向省药品监督管理局提出调剂申请;非定点医院申请调剂使用透解祛瘟颗粒的,由省药品监督管理局予以优先审批。获调剂的医疗机构可直接向该制剂受托生产企业广东一方制药有限公司申请提供配送。

透解祛瘟颗粒(曾用名:“肺炎1号方”颗粒)是广州市第八人民医院中医科谭行华主任中医师临床经验方。谭行华主任是广东省名中医,师从岭南温病大家广州中医药大学第一附属医院彭胜权教授,他在温病学说理论指导下,拟定治疗新型冠状病毒感染肺炎的中医治则为“清热解毒、疏风透表、益气养阴”,临床应用“肺炎1号方”治疗新型冠状病毒感染的肺炎(轻症)确诊病人50例,经1周临床观察全部患者体温恢复正常,50%患者咳嗽症状消失,52.4%咽痛症状消失,69.6%乏力症状消失,无一例患者转重症。

该项目报至广东省疫情防控指挥部办公室科技攻关组后,获得高度重视,于2020年2月1日召开专家咨询会对该项目进行了评估后认为:“肺炎1号方”能够明显改善新型冠状病毒感染肺炎(轻症)的临床症状,有减少重型肺炎发生的趋势,具有较好的临床价值,拟列为广东省防控新型冠状病毒感染的肺炎疫情科技攻关应急专项。

2月3日,省中医药局、省药品监督管理局组织对广州市第八人民医院“肺炎1号方”颗粒医疗机构制剂应急审批及临床应用进行联合专家论证会。经论证,基于“肺炎1号方”颗粒具有改善新型冠状病毒感染的肺炎(轻症)临床症状和可能减少重型肺炎发生趋势的疗效,同意“肺炎1号方”颗粒按照广东省医疗机构传统中药制剂提出备案申请,并纳入应急审批程序准予附条件备案。该制剂规范名称为"透解祛瘟颗粒"。

20200209071229164.jpg


广东一方制药有限公司副总经理魏梅告诉南方日报记者,一方制药1月31日接到协助广州市第八人民医院申报医院制剂并负责配制的通知后,迅速组织技术、质量、生产及市场相关人员成立了联合攻关小组,按照医疗机构制剂申报相关要求,经过3天3夜奋战完成三批备案产品的生产和检验,向广东省药品监督管理局提交了所有研究资料,获得制剂备案审批。

记者从省药监局的批件中看到,该医院制剂的委托期限到2020年4月3日,即只有2个月的时效,制剂的有效期暂定6个月。魏梅介绍,“肺炎1号方”作为市八医院的院内制剂,按规定只限于在本院内部使用。但特殊时期,省药监局特批该产品在全省定点医院应用于临床。据悉,“肺炎1号方”共涉及16味中药,产品制作周期约为一周。魏梅透露,一方制药会根据市场需要全力保证产能供应。

“肺炎1号方”是广东省药监局应急特批的医院制剂,暂不能用于其他地区。谭行华此前接受记者采访时强调,该方仅限于治疗轻症确诊病人和疑似病人,不可当作预防方使用。广州已组织广州医科大学附属第一医院、广东省中医院、广州市中医院等医院协同攻关,未来争取摸索出针对重症患者的“肺炎方”。

上述通知也提到,广州市第八人民医院作为医疗机构制剂透解祛瘟颗粒的责任主体,应持续关注制剂使用过程中可能出现的不良反应,并采取有效的风险控制措施。调剂使用该制剂的医疗机构如在使用过程中出现不良反应的,应同时报送省药品不良反应监测中心及广州市第八人民医院。
Google translate with highlight by me:

"Pneumonia No. 1" was approved for use in 30 designated hospitals in Guangdong

2020-02-09 07:21:51 Source: Nanfang Daily

According to the Nanfang Daily report on February 8, on the 8th, the official website of the Guangdong Drug Administration released the latest news. It has approved that the Tongjie Quwen Granule (formerly known as "pneumonia No. 1") applied by the Eighth People's Hospital of Guangzhou would be used for clinical treatment for 30 NCP pneumonia designated hospitals in the province. Non-designated hospitals applying for treatment used will be given priority approval by the Provincial Drug Administration.

The notice jointly issued by the Provincial Drug Administration, the Health and Health Commission and the Chinese Medicine Bureau pointed out that during the epidemic period, hospitals with pneumonitis infected by new coronavirus infection in Guangdong province were allowed to treat hospitals directly, according to clinical needs, to directly adjust the use of Tongjie Quwen granules, without requiring The Provincial Drug Supervision Administration filed a transfer application; if a non-scheduled hospital applied for the transfer of the use of Qingjie Quwen granules, the Provincial Drug Supervision Administration would give priority to approval. The transferred medical institution may apply directly to Guangdong Yifang Pharmaceutical Co., Ltd., the manufacturer of the preparation, to provide distribution.

Tuanjie Quwen Granules (formerly known as "Pneumonia No. 1 Recipe" granules) is the clinical experience prescription of Tan Xinghua, the director of the Chinese Medicine Department of Guangzhou Eighth People's Hospital. Director Tan Xinghua is a famous Chinese medicine practitioner in Guangdong Province. Student of
Lingnan fever disease expert, Professor Peng Shengquan of the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine. Under the guidance of the theory of fever disease theory, the Chinese medicine treatment for the treatment of NCP pneumonia is "clearing heat and detoxifying, clearing wind and clearing the surface, and nourishing qi and nourishing yin". Clinical application of "Pneumonia No. 1" in the treatment of 50 patients with (mild) diagnosed NCP infection, after 1 week of clinical observation, all patients' body temperature returned to normal, coughing symptoms disappear in 50% of patients, 52.4% of sore throat symptoms disappeared, 69.6% of fatigue symptoms disappeared, none of the patients turn into severe case.

The project was reported to the Scientific and Technological Research and Development Team of the Office of the Guangdong Provincial Epidemic Prevention and Control Headquarters, and received high attention. On February 1, 2020, an expert consultation meeting was held to evaluate the project and it was concluded that "Pneumonia No. 1" could significantly improve the clinical symptoms of NCP-infected pneumonia (mild) and have a tendency to reduce the occurrence of severe pneumonia and have good clinical value. It is planned to be listed as a special emergency project for the prevention and control of pneumonia in NCP infection in Guangdong Province.

On February 3, the Provincial Bureau of Traditional Chinese Medicine and the Provincial Drug Administration organized a joint expert demonstration meeting on the emergency approval and clinical application of preparations for the "Pneumonia No. 1" granule medical institution in Guangzhou Eighth People's Hospital. It has been demonstrated that the particles based on "Pneumonia No.1 Prescription" have the effect of improving the clinical symptoms of new coronavirus infection of pneumonia (mild) and may reduce the tendency of severe pneumonia. It is agreed that the "Pneumonia No.1 Prescription" granules follow the traditional Chinese medicine of Guangdong medical institutions Preparations are filed for filing and incorporated into emergency approval procedures to allow conditional filing. The specification name of this preparation is "Tongjie Quwen Granules".

Wei Mei, deputy general manager of Guangdong Yifang Pharmaceutical Co., Ltd., told the Nanfang Daily reporter that on January 31, Yifang Pharmaceutical quickly organized technology, quality, production and market-related issues after receiving a notification to assist Guangzhou Eighth People's Hospital in applying for hospital preparations and responsible for preparation. The personnel set up a joint tackling team to complete the production and inspection of three batches of recorded products in 3 days and 3 nights in accordance with the requirements of the medical institution's preparation declaration, submitted all the research materials to the Guangdong Drug Administration, and obtained the preparation for approval.

The reporter saw from the approval of the Provincial Drug Supervision Bureau that the commission period for the preparation of the hospital is April 3, 2020, which is only 2 months, and the validity of the preparation is tentatively set for 6 months. Wei Mei introduced that "Pneumonia No. 1", as an in-hospital preparation of the Eighth Hospital of the City, was limited to use within the hospital according to regulations. But in a special period, the Provincial Drug Administration specifically approved the product for clinical application in designated hospitals across the province. It is reported that "Pneumonia No. 1" involves a total of 16 traditional Chinese medicines, and the product production cycle is about one week. Wei Mei revealed that one side of the pharmaceutical industry will fully guarantee the supply of capacity according to market needs.

"Pneumonia No. 1" is a hospital preparation specially approved by the Guangdong Provincial Drug Administration for emergency use and cannot be used in other regions for the time being. Tan Xinghua previously emphasized in an interview with reporters that the party is limited to treating patients with mild diagnosis and suspected patients, and cannot be used as a preventive party. Guangzhou has organized the First Affiliated Hospital of Guangzhou Medical University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou Hospital of Traditional Chinese Medicine and other hospitals to cooperate in tackling key problems, and strive to find a "pneumonia prescription" for severe patients in the future.

The above notice also mentioned that Guangzhou No. 8 People's Hospital, as the responsible body for the preparation of Jiexiuquwen granules in medical institutions, should continue to pay attention to possible adverse reactions during the use of the preparations and take effective risk control measures. Medical institutions that use this preparation should report to the Provincial Adverse Drug Reaction Monitoring Center and the Eighth People's Hospital of Guangzhou if any adverse reactions occur during the use.
 
Last edited:

Users Who Are Viewing This Thread (Total: 1, Members: 0, Guests: 1)


Back
Top Bottom